Clinical trial
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
- Lead sponsor
- Assistance Publique Hopitaux De Marseille
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2014
- Completion date
- September 30, 2019
- Enrollment
- 230 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
the coagulolytic balance, the mortality rate, the performance used to evaluate the principal objective are technical performances, sensibility and specificity of the tests